top of page

As the result of a partnership between our two companies Nautilus Life Science (USA) and HEMAP AG (Switzerland), and with offices both in the USA and in Europe, we developed The Bridge concept and provide expertise and in-depth European market insights for US-based Biotech companies to successfully enter the European pharmaceutical market (see Press Release from 04-Oct-2023).

It is important to note that we provide independent advice without financial interest regarding selected expansion strategy and implementation.

We have decades of hands-on job experience and completed numerous consulting projects (Pharma, Biotech) in various European countries, in a wide range of functions and across a broad array of therapeutic areas, providing the necessary expertise to navigate the complexity of a European market entry.

We know the European pharmaceutical market from hands-on experience - not from textbooks.

Dr. Thomas Berthold.png
Thomas Berthold, Ph.D.

Owner & Principal at Nautilus Life Science (Sarasota, USA)

 

23 years international & global career with Janssen Pharma / Biotech (Johnson & Johnson) and Desitin Pharmaceuticals, from Sales Rep to Management Board member; in Sales, Marketing, Business Analytics, R&D, Portfolio Management, Finance, Business Development.


Entrepreneurial Business Consultant in Life Science (Marketing, Medical, Launch Readiness, Epidemiology, Portfolio Management, L&A, M&A) since 2011. Many years of international and cross-cultural experience from positions and projects in several European countries and the USA.

Author of several scientific publications in Biology.
PhD in Biology, University of Hamburg, Germany; Post doc Researcher with German Research Foundation; Research Associate, British Museum of Natural History (UK), Danish Bilharziasis Laboratory (Denmark), Royal Museum of Central Africa (Belgium)

Nautilus Life Science logo.png
Bjorn Grob - Bild_2 (002).jpg
Bjoern Grob, M.Sc.

Partner at HEMAP AG (Zuerich, Switzerland)

20 years successful international career with Janssen Pharma / Biotech (Johnson & Johnson) and Pharmacia & Upjohn, from Sales Rep to Business Unit Head with full P&L responsibility to Management Board member; in Sales, Marketing, Life Cycle Management, Market Access, Business Development and Change Management.


Entrepreneurial Business Consultant for Health Economics and Market Access since 2019.
Broad international and cross-cultural experience from numerous positions and assignments in several European countries and operating companies. Author of several scientific publications in Biology and Health Economics.


MSc in Anthropology and Molecular Biology, University of Zuerich, (Switzerland); 
Research Associate, University of Wisconsin (USA) & Cambridge University (UK); Diploma in Health Economics, European School of Health Economics
.

hemap logo wo web.jpg
US Biotech to Europe.png

Tom and Bjoern will jointly lead all projects. As per project need, we will add specialists from our teams in Europe and the US.

For each project, the client has one point-of-contact and one point-of-contract (i.e. one project-contract only).

Our Therapeutic Area experience:
TherAreaexp-b.jpg
Our European job experience (Pharma & Biotech):
EU job experience.jpg
Clients The Bridge.jpg
bottom of page